Formalin-inactivated EV71 vaccine candidate induced cross-neutralizing antibody against subgenotypes B1, B4, B5 and C4A in adult volunteers.
about
Epidemiological Research on Hand, Foot, and Mouth Disease in Mainland ChinaRecent Progress towards Novel EV71 Anti-Therapeutics and VaccinesIs a multivalent hand, foot, and mouth disease vaccine feasible?Inactivated Enterovirus 71 Vaccine Produced by 200-L Scale Serum-Free Microcarrier Bioreactor System Provides Cross-Protective Efficacy in Human SCARB2 Transgenic MouseThe Current Status of the Disease Caused by Enterovirus 71 Infections: Epidemiology, Pathogenesis, Molecular Epidemiology, and Vaccine DevelopmentSeroepidemiology of Coxsackievirus A6, Coxsackievirus A16, and Enterovirus 71 Infections among Children and Adolescents in Singapore, 2008-2010Enterovirus 71 infection and vaccines.EV71 vaccine, a new tool to control outbreaks of hand, foot and mouth disease (HFMD).An inactivated hand-foot-and-mouth disease vaccine using the enterovirus 71 (C4a) strain isolated from a Korean patient induces a strong immunogenic response in mice.Analysis of cross-reactive neutralizing antibodies in human HFMD serum with an EV71 pseudovirus-based assay.Long-term immunogenicity studies of formalin-inactivated enterovirus 71 whole-virion vaccine in macaques.EV71 vaccine, an invaluable gift for children.Complete sequence analysis and antiviral screening of medicinal plants for human coxsackievirus a16 isolated in KoreaRecombinant adeno-vaccine expressing enterovirus 71-like particles against hand, foot, and mouth diseaseHand, Foot, and Mouth Disease in China: Modeling Epidemic Dynamics of Enterovirus Serotypes and Implications for Vaccination.The compatibility of inactivated-Enterovirus 71 vaccination with Coxsackievirus A16 and Poliovirus immunizations in humans and animals.EV71 virus-like particles produced by co-expression of capsid proteins in yeast cells elicit humoral protective response against EV71 lethal challengeAntiviral activity of Lactobacillus reuteri Protectis against Coxsackievirus A and Enterovirus 71 infection in human skeletal muscle and colon cell lines.Comprehensive safety assessment of a human inactivated diploid enterovirus 71 vaccine based on a phase III clinical trialPrediction of Protection against Asian Enterovirus 71 Outbreak Strains by Cross-neutralizing Capacity of Serum from Dutch Donors, The NetherlandsUpdate of enterovirus 71 infection: epidemiology, pathogenesis and vaccine.Development of enterovirus 71 vaccines: from the lab bench to Phase III clinical trials.Update on the development of enterovirus 71 vaccines.Review of enterovirus 71 vaccines.Enterovirus 71: a whole virion inactivated enterovirus 71 vaccine.A Potent Virus-Specific Antibody-Secreting Cell Response to Acute Enterovirus 71 Infection in Children.EV71 vaccines: a first step towards multivalent hand, foot and mouth disease vaccines.Epitope-associated and specificity-focused features of EV71-neutralizing antibody repertoires from plasmablasts of infected children.Epidemiology of Recurrent Hand, Foot and Mouth Disease, China, 2008-2015.Hand, foot and mouth disease and herpangina caused by enterovirus A71 infections: a review of enterovirus A71 molecular epidemiology, pathogenesis, and current vaccine development
P2860
Q26774357-A57F7CEA-E6C2-4858-9097-BABF5001CA67Q26775734-DA58ADC2-B7AA-4B83-952E-EC609F9A23CCQ27010349-DC40C2AC-42FB-42BC-8C11-7F13624A6FF8Q27321616-D61018F8-481D-40AD-AB1D-8604BB14415FQ28066400-FBFA62FF-3A00-4A57-A4F5-493B7384CA49Q28547485-B6391361-5B13-40CB-971D-8C2976E6630AQ30238518-83741A52-AF1C-419E-8576-0A5E845C8D45Q30383172-5085BD28-C1C5-4C77-B8CE-EA4739455558Q33724967-2C9CC0F0-39A7-472A-9E8A-088545EEC04DQ33806668-14C256A1-7B80-455C-BF31-410E3CD22B93Q34149853-14661AD1-6BB5-4E3E-BEE0-EDBC8D1995CAQ34540559-4D1A850B-1016-4F46-8F81-639467AA3936Q35138013-E7CCC726-96B9-4DA5-ACD6-44A5B4584BA6Q35345853-8D26BB47-0164-4FDE-A1F8-E77A133F6E77Q35925175-3647CF68-C265-45BE-800B-B3833469D840Q36389012-0D7E9B50-AA1A-4256-8B14-6DADCA3C5817Q36496385-D26502A1-E76C-498B-9326-18D55B258617Q37037951-2FCF983C-7358-4BAC-950E-BCA2206C40B1Q37130763-A71AD96A-6BF5-409B-B32D-A83276B8DEDFQ37196295-9FE7B925-2C3A-430C-9E2E-EDEEAF9CB129Q38192021-FDEC308C-0921-47A7-8D3C-D11375F9B8ECQ38195326-14080DC9-EC61-46DB-B163-78FECD92AAD3Q38225695-7A65A0B8-1861-4B3D-B3B8-E413283D8B46Q38263484-07D671A7-2992-4E1A-BFB6-DA84AA43A809Q38840182-FF429969-19ED-4B4C-B982-D32407DE0682Q40168001-4FDDCF9E-7D29-4CC2-9847-6134875AD841Q41583962-050AF286-BBEC-43FB-A91D-A92CB16D6F05Q41925938-0C496488-582E-42CC-BD04-613532A2C2CAQ49820089-A4525443-021F-40CB-9D2B-6CF675CC119FQ59139034-5A42F795-ADF7-490F-AB05-93C6AA5CCBE4
P2860
Formalin-inactivated EV71 vaccine candidate induced cross-neutralizing antibody against subgenotypes B1, B4, B5 and C4A in adult volunteers.
description
2013 nî lūn-bûn
@nan
2013 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Formalin-inactivated EV71 vacc ...... 5 and C4A in adult volunteers.
@ast
Formalin-inactivated EV71 vacc ...... 5 and C4A in adult volunteers.
@en
type
label
Formalin-inactivated EV71 vacc ...... 5 and C4A in adult volunteers.
@ast
Formalin-inactivated EV71 vacc ...... 5 and C4A in adult volunteers.
@en
prefLabel
Formalin-inactivated EV71 vacc ...... 5 and C4A in adult volunteers.
@ast
Formalin-inactivated EV71 vacc ...... 5 and C4A in adult volunteers.
@en
P2093
P2860
P50
P1433
P1476
Formalin-inactivated EV71 vacc ...... 5 and C4A in adult volunteers.
@en
P2093
Ai-Hsiang Chou
Amanda Tsao
Chang-Phone Fung
Chien-Long Wu
Jen-Ron Chiang
Ju-Lan Huang
Jui-Yuan Chang
Mei-Hua Hu
Pele Choi-Sing Chong
P2860
P304
P356
10.1371/JOURNAL.PONE.0079783
P407
P577
2013-11-21T00:00:00Z